Study Name Principal Investigator
(Augustus) An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients with Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention Sharma, Gyanendra
(CONNECT-HF) Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure Weintraub, Neal
(Emporer Preserved) Emperor- HRpEF: A phase III, randomized, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10mg compared to placebo, in patients with chronic Heart Failure with preserved Ejection Fraction (HFpEF) Weintraub, Neal
(Evaluate-HF) A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled, forced-titration, 12-week comparison of combined angiotensin-neprilysin inhibition with sacubitril and valsartan versus enalapril on changes in central aortic stiffness in patients with heart failure and reduced ejection fraction (HFrEF) Dunlap, Stephanie
(Heart-FID) A Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Injectafer Weintraub, Neal
(SMART-MSP) Strategic MAnagement to Improve CRT Using Multi-Site Pacing, Post Approval Study Hreibe, Haitham
(TDE-HF-301) A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension (PH) in Heart Failure with Preserved Ejection Fraction (HFpEF) McDonough, Clark
Emperor Reduced: A phase III randomized, double-blind trial to evaluate efficacy and safety of once daily empagliflozin 10mg compared to placebo, in patients with chronic Heart Failure and reduced Ejection Fraction (HFrEF) Weintraub, Neal
Promote Family Centered DASH Diet Adherence in heart Failure Patients Young, Lufei
Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE - A5332) MacArthur, Rodger
RESEARCH. INNOVATION. DISCOVERY.